This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2019 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.99% per year. These returns cover a period from January 1, 1988 through January 7, 2019. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.
Visit performance for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
Dendreon (DNDN) in Focus: Stock Up 9.4%
Dendreon Corp. was a big mover last session, as the company saw its shares rise over 9% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $1.32 to $1.40 in the past one-month time frame.
The company has seen 1 positive estimate revision in the past month, while its Zacks Consensus Estimate, which is pegged at a loss, remained unchanged over the same period, However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Dendreon Corp currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other attractive players in the med-biomed industry include Heska Corporation (HSKA - Free Report) , Illumina Inc. (ILMN - Free Report) and Cambrex Corporation. (CBM - Free Report) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>